General Information of Drug Transporter (DT)
DT ID DTD0322 Transporter Info
Gene Name SLC37A1
Transporter Name Glycerol-3-phosphate permease
Gene ID
54020
UniProt ID
P57057
Epigenetic Regulations of This DT (EGR)

Methylation

  Atypical teratoid rhabdoid tumor

         20 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC37A1 in atypical teratoid rhabdoid tumor [ 1 ]

Location

5'UTR (cg00549412)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.34E+00 Statistic Test p-value:5.33E-09; Z-score:1.54E+00

Methylation in Case

7.56E-01 (Median) Methylation in Control 5.63E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon2

Methylation of SLC37A1 in atypical teratoid rhabdoid tumor [ 1 ]

Location

5'UTR (cg01879556)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.34E+00 Statistic Test p-value:1.18E-08; Z-score:1.93E+00

Methylation in Case

8.52E-01 (Median) Methylation in Control 6.34E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon3

Methylation of SLC37A1 in atypical teratoid rhabdoid tumor [ 1 ]

Location

5'UTR (cg06579790)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.51E+00 Statistic Test p-value:6.48E-08; Z-score:-1.42E+00

Methylation in Case

3.27E-01 (Median) Methylation in Control 4.93E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon4

Methylation of SLC37A1 in atypical teratoid rhabdoid tumor [ 1 ]

Location

5'UTR (cg09546172)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.90E+00 Statistic Test p-value:1.85E-07; Z-score:-1.86E+00

Methylation in Case

1.55E-01 (Median) Methylation in Control 2.95E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon5

Methylation of SLC37A1 in atypical teratoid rhabdoid tumor [ 1 ]

Location

5'UTR (cg12993026)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.09E+00 Statistic Test p-value:4.23E-07; Z-score:-1.29E+00

Methylation in Case

8.10E-01 (Median) Methylation in Control 8.80E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon6

Methylation of SLC37A1 in atypical teratoid rhabdoid tumor [ 1 ]

Location

5'UTR (cg17398613)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.32E+00 Statistic Test p-value:1.93E-06; Z-score:-1.34E+00

Methylation in Case

3.21E-01 (Median) Methylation in Control 4.23E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon7

Methylation of SLC37A1 in atypical teratoid rhabdoid tumor [ 1 ]

Location

5'UTR (cg22599036)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.17E+00 Statistic Test p-value:6.35E-06; Z-score:7.76E-01

Methylation in Case

8.09E-01 (Median) Methylation in Control 6.90E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon8

Methylation of SLC37A1 in atypical teratoid rhabdoid tumor [ 1 ]

Location

5'UTR (cg23336810)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.26E+00 Statistic Test p-value:7.03E-06; Z-score:1.34E+00

Methylation in Case

8.62E-01 (Median) Methylation in Control 6.83E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon9

Methylation of SLC37A1 in atypical teratoid rhabdoid tumor [ 1 ]

Location

Body (cg00288945)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.31E+00 Statistic Test p-value:1.99E-05; Z-score:-1.08E+00

Methylation in Case

5.69E-01 (Median) Methylation in Control 7.46E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon10

Methylation of SLC37A1 in atypical teratoid rhabdoid tumor [ 1 ]

Location

Body (cg04096368)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.15E+00 Statistic Test p-value:5.55E-04; Z-score:-9.61E-01

Methylation in Case

6.69E-01 (Median) Methylation in Control 7.66E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon11

Methylation of SLC37A1 in atypical teratoid rhabdoid tumor [ 1 ]

Location

Body (cg04192258)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.93E+00 Statistic Test p-value:5.99E-04; Z-score:-8.37E-01

Methylation in Case

1.26E-01 (Median) Methylation in Control 2.42E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon12

Methylation of SLC37A1 in atypical teratoid rhabdoid tumor [ 1 ]

Location

Body (cg08193480)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.06E+00 Statistic Test p-value:5.60E-03; Z-score:2.81E-01

Methylation in Case

1.88E-02 (Median) Methylation in Control 1.77E-02 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon13

Methylation of SLC37A1 in atypical teratoid rhabdoid tumor [ 1 ]

Location

Body (cg08407901)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.23E+00 Statistic Test p-value:6.16E-03; Z-score:-9.02E-01

Methylation in Case

5.36E-01 (Median) Methylation in Control 6.57E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon14

Methylation of SLC37A1 in atypical teratoid rhabdoid tumor [ 1 ]

Location

Body (cg08529312)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.01E+00 Statistic Test p-value:7.23E-03; Z-score:6.31E-02

Methylation in Case

8.50E-02 (Median) Methylation in Control 8.38E-02 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon15

Methylation of SLC37A1 in atypical teratoid rhabdoid tumor [ 1 ]

Location

Body (cg11453546)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.01E+00 Statistic Test p-value:2.25E-02; Z-score:-4.95E-01

Methylation in Case

9.58E-01 (Median) Methylation in Control 9.67E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon16

Methylation of SLC37A1 in atypical teratoid rhabdoid tumor [ 1 ]

Location

Body (cg12409874)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.08E+00 Statistic Test p-value:2.76E-02; Z-score:3.37E-01

Methylation in Case

3.37E-01 (Median) Methylation in Control 3.14E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon17

Methylation of SLC37A1 in atypical teratoid rhabdoid tumor [ 1 ]

Location

Body (cg12913778)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.16E+00 Statistic Test p-value:3.17E-02; Z-score:5.11E-01

Methylation in Case

5.29E-01 (Median) Methylation in Control 4.55E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon18

Methylation of SLC37A1 in atypical teratoid rhabdoid tumor [ 1 ]

Location

Body (cg13128052)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.04E+00 Statistic Test p-value:3.29E-02; Z-score:5.14E-01

Methylation in Case

8.81E-01 (Median) Methylation in Control 8.45E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon19

Methylation of SLC37A1 in atypical teratoid rhabdoid tumor [ 1 ]

Location

Body (cg13960334)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.15E+00 Statistic Test p-value:4.02E-02; Z-score:-2.01E-01

Methylation in Case

1.57E-01 (Median) Methylation in Control 1.80E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon20

Methylation of SLC37A1 in atypical teratoid rhabdoid tumor [ 1 ]

Location

3'UTR (cg24141725)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.32E+00 Statistic Test p-value:1.21E-09; Z-score:-1.49E+00

Methylation in Case

4.89E-01 (Median) Methylation in Control 6.45E-01 (Median)

Studied Phenotype

Atypical teratoid rhabdoid tumor[ ICD-11:2A00.1Y]

Experimental Material

Patient tissue samples

  Bladder cancer

         12 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC37A1 in bladder cancer [ 2 ]

Location

5'UTR (cg23336810)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-2.41E+00 Statistic Test p-value:3.00E-08; Z-score:-7.60E+00

Methylation in Case

2.97E-01 (Median) Methylation in Control 7.14E-01 (Median)

Studied Phenotype

Bladder cancer[ ICD-11:2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon2

Methylation of SLC37A1 in bladder cancer [ 2 ]

Location

5'UTR (cg00549412)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.55E+00 Statistic Test p-value:7.23E-06; Z-score:-5.05E+00

Methylation in Case

4.21E-01 (Median) Methylation in Control 6.53E-01 (Median)

Studied Phenotype

Bladder cancer[ ICD-11:2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon3

Methylation of SLC37A1 in bladder cancer [ 2 ]

Location

5'UTR (cg09546172)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.31E+00 Statistic Test p-value:1.28E-05; Z-score:-3.65E+00

Methylation in Case

1.00E-01 (Median) Methylation in Control 1.32E-01 (Median)

Studied Phenotype

Bladder cancer[ ICD-11:2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon4

Methylation of SLC37A1 in bladder cancer [ 2 ]

Location

TSS1500 (cg08599496)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.16E+00 Statistic Test p-value:5.37E-06; Z-score:-4.54E+00

Methylation in Case

7.05E-01 (Median) Methylation in Control 8.17E-01 (Median)

Studied Phenotype

Bladder cancer[ ICD-11:2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon5

Methylation of SLC37A1 in bladder cancer [ 2 ]

Location

TSS1500 (cg17218342)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.08E+00 Statistic Test p-value:1.90E-04; Z-score:-3.78E+00

Methylation in Case

7.22E-01 (Median) Methylation in Control 7.79E-01 (Median)

Studied Phenotype

Bladder cancer[ ICD-11:2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon6

Methylation of SLC37A1 in bladder cancer [ 2 ]

Location

TSS1500 (cg13265003)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.11E+00 Statistic Test p-value:3.90E-03; Z-score:-2.07E+00

Methylation in Case

5.89E-01 (Median) Methylation in Control 6.52E-01 (Median)

Studied Phenotype

Bladder cancer[ ICD-11:2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon7

Methylation of SLC37A1 in bladder cancer [ 2 ]

Location

Body (cg04096368)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.32E+00 Statistic Test p-value:1.54E-07; Z-score:-6.03E+00

Methylation in Case

5.24E-01 (Median) Methylation in Control 6.93E-01 (Median)

Studied Phenotype

Bladder cancer[ ICD-11:2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon8

Methylation of SLC37A1 in bladder cancer [ 2 ]

Location

Body (cg12409874)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.20E+00 Statistic Test p-value:3.52E-05; Z-score:-4.91E+00

Methylation in Case

7.13E-01 (Median) Methylation in Control 8.52E-01 (Median)

Studied Phenotype

Bladder cancer[ ICD-11:2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon9

Methylation of SLC37A1 in bladder cancer [ 2 ]

Location

Body (cg18478353)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.08E+00 Statistic Test p-value:3.52E-03; Z-score:4.04E+00

Methylation in Case

7.31E-01 (Median) Methylation in Control 6.76E-01 (Median)

Studied Phenotype

Bladder cancer[ ICD-11:2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon10

Methylation of SLC37A1 in bladder cancer [ 2 ]

Location

Body (cg08193480)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.02E+00 Statistic Test p-value:7.55E-03; Z-score:-1.02E+00

Methylation in Case

8.27E-01 (Median) Methylation in Control 8.46E-01 (Median)

Studied Phenotype

Bladder cancer[ ICD-11:2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon11

Methylation of SLC37A1 in bladder cancer [ 2 ]

Location

Body (cg08529312)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.01E+00 Statistic Test p-value:1.69E-02; Z-score:-6.18E-01

Methylation in Case

8.00E-01 (Median) Methylation in Control 8.09E-01 (Median)

Studied Phenotype

Bladder cancer[ ICD-11:2C94]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon12

Methylation of SLC37A1 in bladder cancer [ 2 ]

Location

Body (cg00288945)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.03E+00 Statistic Test p-value:3.14E-02; Z-score:-1.27E+00

Methylation in Case

8.35E-01 (Median) Methylation in Control 8.60E-01 (Median)

Studied Phenotype

Bladder cancer[ ICD-11:2C94]

Experimental Material

Patient tissue samples

  Breast cancer

         17 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC37A1 in breast cancer [ 3 ]

Location

5'UTR (cg17398613)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.07E+00 Statistic Test p-value:3.70E-09; Z-score:1.02E+00

Methylation in Case

7.53E-01 (Median) Methylation in Control 7.04E-01 (Median)

Studied Phenotype

Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon2

Methylation of SLC37A1 in breast cancer [ 3 ]

Location

5'UTR (cg23336810)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.19E+00 Statistic Test p-value:2.89E-06; Z-score:-1.22E+00

Methylation in Case

5.50E-01 (Median) Methylation in Control 6.55E-01 (Median)

Studied Phenotype

Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon3

Methylation of SLC37A1 in breast cancer [ 3 ]

Location

5'UTR (cg09546172)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.39E+00 Statistic Test p-value:4.50E-06; Z-score:-1.10E+00

Methylation in Case

9.30E-02 (Median) Methylation in Control 1.29E-01 (Median)

Studied Phenotype

Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon4

Methylation of SLC37A1 in breast cancer [ 3 ]

Location

TSS1500 (cg13265003)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.05E+00 Statistic Test p-value:3.15E-06; Z-score:-6.75E-01

Methylation in Case

6.74E-01 (Median) Methylation in Control 7.04E-01 (Median)

Studied Phenotype

Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon5

Methylation of SLC37A1 in breast cancer [ 3 ]

Location

TSS1500 (cg17218342)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.06E+00 Statistic Test p-value:1.36E-05; Z-score:-1.20E+00

Methylation in Case

7.55E-01 (Median) Methylation in Control 8.01E-01 (Median)

Studied Phenotype

Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon6

Methylation of SLC37A1 in breast cancer [ 3 ]

Location

TSS1500 (cg08599496)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.11E+00 Statistic Test p-value:2.28E-02; Z-score:-8.74E-01

Methylation in Case

6.64E-01 (Median) Methylation in Control 7.39E-01 (Median)

Studied Phenotype

Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon7

Methylation of SLC37A1 in breast cancer [ 3 ]

Location

TSS200 (cg20002045)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.05E+00 Statistic Test p-value:4.59E-02; Z-score:1.12E+00

Methylation in Case

8.46E-01 (Median) Methylation in Control 8.07E-01 (Median)

Studied Phenotype

Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon8

Methylation of SLC37A1 in breast cancer [ 3 ]

Location

Body (cg04096368)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.14E+00 Statistic Test p-value:9.92E-09; Z-score:-1.69E+00

Methylation in Case

5.75E-01 (Median) Methylation in Control 6.55E-01 (Median)

Studied Phenotype

Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon9

Methylation of SLC37A1 in breast cancer [ 3 ]

Location

Body (cg18478353)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.07E+00 Statistic Test p-value:3.41E-08; Z-score:1.17E+00

Methylation in Case

7.23E-01 (Median) Methylation in Control 6.76E-01 (Median)

Studied Phenotype

Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon10

Methylation of SLC37A1 in breast cancer [ 3 ]

Location

Body (cg13960334)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.08E+00 Statistic Test p-value:2.98E-06; Z-score:9.40E-01

Methylation in Case

9.54E-01 (Median) Methylation in Control 8.83E-01 (Median)

Studied Phenotype

Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon11

Methylation of SLC37A1 in breast cancer [ 3 ]

Location

Body (cg08529312)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.09E+00 Statistic Test p-value:1.03E-05; Z-score:9.00E-01

Methylation in Case

7.86E-01 (Median) Methylation in Control 7.20E-01 (Median)

Studied Phenotype

Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon12

Methylation of SLC37A1 in breast cancer [ 3 ]

Location

Body (cg12409874)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.03E+00 Statistic Test p-value:1.58E-04; Z-score:-7.28E-01

Methylation in Case

8.55E-01 (Median) Methylation in Control 8.79E-01 (Median)

Studied Phenotype

Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon13

Methylation of SLC37A1 in breast cancer [ 3 ]

Location

Body (cg13128052)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.02E+00 Statistic Test p-value:2.12E-03; Z-score:-6.30E-01

Methylation in Case

8.18E-01 (Median) Methylation in Control 8.33E-01 (Median)

Studied Phenotype

Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon14

Methylation of SLC37A1 in breast cancer [ 3 ]

Location

Body (cg08193480)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.04E+00 Statistic Test p-value:2.45E-02; Z-score:4.64E-01

Methylation in Case

7.86E-01 (Median) Methylation in Control 7.57E-01 (Median)

Studied Phenotype

Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon15

Methylation of SLC37A1 in breast cancer [ 3 ]

Location

Body (cg12913778)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.06E+00 Statistic Test p-value:2.81E-02; Z-score:5.43E-01

Methylation in Case

5.06E-01 (Median) Methylation in Control 4.79E-01 (Median)

Studied Phenotype

Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon16

Methylation of SLC37A1 in breast cancer [ 3 ]

Location

Body (cg00288945)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.02E+00 Statistic Test p-value:2.86E-02; Z-score:-2.12E-01

Methylation in Case

8.41E-01 (Median) Methylation in Control 8.56E-01 (Median)

Studied Phenotype

Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon17

Methylation of SLC37A1 in breast cancer [ 3 ]

Location

3'UTR (cg24141725)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.01E+00 Statistic Test p-value:5.79E-03; Z-score:-4.14E-01

Methylation in Case

9.25E-01 (Median) Methylation in Control 9.31E-01 (Median)

Studied Phenotype

Breast cancer[ ICD-11:2C60-2C6Z]

Experimental Material

Patient tissue samples

  Renal cell carcinoma

           4 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC37A1 in clear cell renal cell carcinoma [ 4 ]

Location

5'UTR (cg09546172)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.50E+00 Statistic Test p-value:4.50E-09; Z-score:-1.36E+00

Methylation in Case

5.91E-02 (Median) Methylation in Control 8.88E-02 (Median)

Studied Phenotype

Renal cell carcinoma[ ICD-11:2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon2

Methylation of SLC37A1 in clear cell renal cell carcinoma [ 4 ]

Location

5'UTR (cg23336810)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.19E+00 Statistic Test p-value:5.62E-04; Z-score:-2.38E+00

Methylation in Case

6.86E-01 (Median) Methylation in Control 8.17E-01 (Median)

Studied Phenotype

Renal cell carcinoma[ ICD-11:2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon3

Methylation of SLC37A1 in clear cell renal cell carcinoma [ 4 ]

Location

5'UTR (cg22599036)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.10E+00 Statistic Test p-value:2.22E-02; Z-score:4.36E-01

Methylation in Case

2.13E-02 (Median) Methylation in Control 1.94E-02 (Median)

Studied Phenotype

Renal cell carcinoma[ ICD-11:2C90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon4

Methylation of SLC37A1 in clear cell renal cell carcinoma [ 4 ]

Location

Body (cg08193480)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.01E+00 Statistic Test p-value:5.13E-03; Z-score:-1.05E+00

Methylation in Case

9.33E-01 (Median) Methylation in Control 9.43E-01 (Median)

Studied Phenotype

Renal cell carcinoma[ ICD-11:2C90]

Experimental Material

Patient tissue samples

  Colorectal cancer

         13 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC37A1 in colorectal cancer [ 5 ]

Location

5'UTR (cg00549412)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.09E+00 Statistic Test p-value:2.03E-04; Z-score:-1.03E+00

Methylation in Case

6.99E-01 (Median) Methylation in Control 7.63E-01 (Median)

Studied Phenotype

Colorectal cancer[ ICD-11:2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon2

Methylation of SLC37A1 in colorectal cancer [ 5 ]

Location

5'UTR (cg06579790)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.29E+00 Statistic Test p-value:4.55E-03; Z-score:-5.25E-01

Methylation in Case

2.60E-02 (Median) Methylation in Control 3.35E-02 (Median)

Studied Phenotype

Colorectal cancer[ ICD-11:2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon3

Methylation of SLC37A1 in colorectal cancer [ 5 ]

Location

5'UTR (cg17398613)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.01E+00 Statistic Test p-value:1.51E-02; Z-score:-3.27E-01

Methylation in Case

8.98E-01 (Median) Methylation in Control 9.07E-01 (Median)

Studied Phenotype

Colorectal cancer[ ICD-11:2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon4

Methylation of SLC37A1 in colorectal cancer [ 5 ]

Location

TSS1500 (cg08599496)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.03E+00 Statistic Test p-value:1.12E-08; Z-score:-2.10E+00

Methylation in Case

8.92E-01 (Median) Methylation in Control 9.17E-01 (Median)

Studied Phenotype

Colorectal cancer[ ICD-11:2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon5

Methylation of SLC37A1 in colorectal cancer [ 5 ]

Location

TSS1500 (cg13265003)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.07E+00 Statistic Test p-value:3.63E-05; Z-score:-1.15E+00

Methylation in Case

7.89E-01 (Median) Methylation in Control 8.43E-01 (Median)

Studied Phenotype

Colorectal cancer[ ICD-11:2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon6

Methylation of SLC37A1 in colorectal cancer [ 5 ]

Location

TSS200 (cg20002045)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.00E+00 Statistic Test p-value:4.77E-02; Z-score:-1.52E-01

Methylation in Case

9.35E-01 (Median) Methylation in Control 9.37E-01 (Median)

Studied Phenotype

Colorectal cancer[ ICD-11:2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon7

Methylation of SLC37A1 in colorectal cancer [ 5 ]

Location

Body (cg08529312)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.01E+00 Statistic Test p-value:7.53E-05; Z-score:-9.78E-01

Methylation in Case

9.05E-01 (Median) Methylation in Control 9.17E-01 (Median)

Studied Phenotype

Colorectal cancer[ ICD-11:2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon8

Methylation of SLC37A1 in colorectal cancer [ 5 ]

Location

Body (cg08193480)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.01E+00 Statistic Test p-value:8.91E-04; Z-score:-6.57E-01

Methylation in Case

9.35E-01 (Median) Methylation in Control 9.40E-01 (Median)

Studied Phenotype

Colorectal cancer[ ICD-11:2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon9

Methylation of SLC37A1 in colorectal cancer [ 5 ]

Location

Body (cg11453546)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.09E+00 Statistic Test p-value:1.29E-03; Z-score:-8.77E-01

Methylation in Case

6.59E-01 (Median) Methylation in Control 7.17E-01 (Median)

Studied Phenotype

Colorectal cancer[ ICD-11:2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon10

Methylation of SLC37A1 in colorectal cancer [ 5 ]

Location

Body (cg04192258)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.00E+00 Statistic Test p-value:3.51E-03; Z-score:-1.46E-01

Methylation in Case

9.68E-01 (Median) Methylation in Control 9.69E-01 (Median)

Studied Phenotype

Colorectal cancer[ ICD-11:2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon11

Methylation of SLC37A1 in colorectal cancer [ 5 ]

Location

Body (cg13960334)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.00E+00 Statistic Test p-value:3.18E-02; Z-score:-5.60E-01

Methylation in Case

9.64E-01 (Median) Methylation in Control 9.69E-01 (Median)

Studied Phenotype

Colorectal cancer[ ICD-11:2B91]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon12

Methylation of SLC37A1 in colorectal cancer [ 5 ]

Location

Body (cg18478353)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.01E+00 Statistic Test p-value:4.46E-02; Z-score:-2.41E-01

Methylation in Case

8.78E-01 (Median) Methylation in Control 8.82E-01 (Median)

Studied Phenotype

Colorectal cancer[ ICD-11:2B91]

Experimental Material

Patient tissue samples

  Hepatocellular carcinoma

         15 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC37A1 in hepatocellular carcinoma [ 6 ]

Location

5'UTR (cg23336810)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.07E+00 Statistic Test p-value:4.59E-03; Z-score:9.06E-01

Methylation in Case

8.30E-01 (Median) Methylation in Control 7.76E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon2

Methylation of SLC37A1 in hepatocellular carcinoma [ 6 ]

Location

TSS1500 (cg08599496)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.05E+00 Statistic Test p-value:8.19E-07; Z-score:-1.47E+00

Methylation in Case

7.98E-01 (Median) Methylation in Control 8.37E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon3

Methylation of SLC37A1 in hepatocellular carcinoma [ 6 ]

Location

TSS1500 (cg17218342)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.01E+00 Statistic Test p-value:1.34E-02; Z-score:-2.79E-01

Methylation in Case

8.35E-01 (Median) Methylation in Control 8.46E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon4

Methylation of SLC37A1 in hepatocellular carcinoma [ 6 ]

Location

Body (cg13730736)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.71E+00 Statistic Test p-value:2.71E-19; Z-score:-3.83E+00

Methylation in Case

2.96E-01 (Median) Methylation in Control 5.07E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon5

Methylation of SLC37A1 in hepatocellular carcinoma [ 6 ]

Location

Body (cg08033262)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.67E+00 Statistic Test p-value:1.13E-18; Z-score:-9.23E+00

Methylation in Case

5.02E-01 (Median) Methylation in Control 8.38E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon6

Methylation of SLC37A1 in hepatocellular carcinoma [ 6 ]

Location

Body (cg13960334)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.02E+00 Statistic Test p-value:1.59E-05; Z-score:9.05E-01

Methylation in Case

9.61E-01 (Median) Methylation in Control 9.41E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon7

Methylation of SLC37A1 in hepatocellular carcinoma [ 6 ]

Location

Body (cg12409874)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.04E+00 Statistic Test p-value:1.86E-05; Z-score:-1.35E+00

Methylation in Case

8.42E-01 (Median) Methylation in Control 8.76E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon8

Methylation of SLC37A1 in hepatocellular carcinoma [ 6 ]

Location

Body (cg12913778)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.13E+00 Statistic Test p-value:3.02E-05; Z-score:2.54E+00

Methylation in Case

6.37E-01 (Median) Methylation in Control 5.65E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon9

Methylation of SLC37A1 in hepatocellular carcinoma [ 6 ]

Location

Body (cg04096368)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.02E+00 Statistic Test p-value:4.96E-04; Z-score:-3.69E-01

Methylation in Case

7.94E-01 (Median) Methylation in Control 8.08E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon10

Methylation of SLC37A1 in hepatocellular carcinoma [ 6 ]

Location

Body (cg18478353)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.02E+00 Statistic Test p-value:2.95E-03; Z-score:-5.54E-01

Methylation in Case

7.15E-01 (Median) Methylation in Control 7.31E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon11

Methylation of SLC37A1 in hepatocellular carcinoma [ 6 ]

Location

Body (cg00288945)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.02E+00 Statistic Test p-value:4.00E-03; Z-score:-5.45E-01

Methylation in Case

8.39E-01 (Median) Methylation in Control 8.58E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon12

Methylation of SLC37A1 in hepatocellular carcinoma [ 6 ]

Location

Body (cg11453546)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.04E+00 Statistic Test p-value:1.12E-02; Z-score:5.77E-01

Methylation in Case

7.16E-01 (Median) Methylation in Control 6.87E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon13

Methylation of SLC37A1 in hepatocellular carcinoma [ 6 ]

Location

Body (cg08193480)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.01E+00 Statistic Test p-value:1.56E-02; Z-score:4.79E-01

Methylation in Case

8.52E-01 (Median) Methylation in Control 8.43E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon14

Methylation of SLC37A1 in hepatocellular carcinoma [ 6 ]

Location

Body (cg04192258)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.00E+00 Statistic Test p-value:1.85E-02; Z-score:-4.29E-01

Methylation in Case

9.62E-01 (Median) Methylation in Control 9.67E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon15

Methylation of SLC37A1 in hepatocellular carcinoma [ 6 ]

Location

3'UTR (cg24141725)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.01E+00 Statistic Test p-value:1.25E-02; Z-score:-4.50E-01

Methylation in Case

9.09E-01 (Median) Methylation in Control 9.18E-01 (Median)

Studied Phenotype

Hepatocellular carcinoma[ ICD-11:2C12.02]

Experimental Material

Patient tissue samples

  HIV infection

           9 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC37A1 in HIV infection [ 7 ]

Location

5'UTR (cg00549412)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.10E+00 Statistic Test p-value:1.32E-12; Z-score:1.45E+00

Methylation in Case

7.80E-01 (Median) Methylation in Control 7.11E-01 (Median)

Studied Phenotype

HIV infection[ ICD-11:1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon2

Methylation of SLC37A1 in HIV infection [ 7 ]

Location

5'UTR (cg17398613)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.11E+00 Statistic Test p-value:4.91E-12; Z-score:1.56E+00

Methylation in Case

8.52E-01 (Median) Methylation in Control 7.66E-01 (Median)

Studied Phenotype

HIV infection[ ICD-11:1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon3

Methylation of SLC37A1 in HIV infection [ 7 ]

Location

TSS1500 (cg13265003)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.48E+00 Statistic Test p-value:2.83E-17; Z-score:5.44E+00

Methylation in Case

8.23E-01 (Median) Methylation in Control 5.55E-01 (Median)

Studied Phenotype

HIV infection[ ICD-11:1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon4

Methylation of SLC37A1 in HIV infection [ 7 ]

Location

Body (cg18478353)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.04E+00 Statistic Test p-value:1.29E-05; Z-score:7.23E-01

Methylation in Case

8.04E-01 (Median) Methylation in Control 7.75E-01 (Median)

Studied Phenotype

HIV infection[ ICD-11:1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon5

Methylation of SLC37A1 in HIV infection [ 7 ]

Location

Body (cg00288945)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.04E+00 Statistic Test p-value:1.71E-03; Z-score:-1.09E+00

Methylation in Case

9.09E-01 (Median) Methylation in Control 9.47E-01 (Median)

Studied Phenotype

HIV infection[ ICD-11:1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon6

Methylation of SLC37A1 in HIV infection [ 7 ]

Location

Body (cg12913778)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.04E+00 Statistic Test p-value:1.73E-03; Z-score:6.52E-01

Methylation in Case

6.73E-01 (Median) Methylation in Control 6.46E-01 (Median)

Studied Phenotype

HIV infection[ ICD-11:1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon7

Methylation of SLC37A1 in HIV infection [ 7 ]

Location

Body (cg04096368)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.05E+00 Statistic Test p-value:2.75E-03; Z-score:-1.38E+00

Methylation in Case

8.20E-01 (Median) Methylation in Control 8.62E-01 (Median)

Studied Phenotype

HIV infection[ ICD-11:1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon8

Methylation of SLC37A1 in HIV infection [ 7 ]

Location

Body (cg13128052)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.02E+00 Statistic Test p-value:5.53E-03; Z-score:-6.34E-01

Methylation in Case

8.34E-01 (Median) Methylation in Control 8.49E-01 (Median)

Studied Phenotype

HIV infection[ ICD-11:1C62.Z]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon9

Methylation of SLC37A1 in HIV infection [ 7 ]

Location

Body (cg08529312)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.02E+00 Statistic Test p-value:6.17E-03; Z-score:-7.43E-01

Methylation in Case

8.61E-01 (Median) Methylation in Control 8.78E-01 (Median)

Studied Phenotype

HIV infection[ ICD-11:1C62.Z]

Experimental Material

Patient tissue samples

  Lung adenocarcinoma

           2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC37A1 in lung adenocarcinoma [ 8 ]

Location

5'UTR (cg17398613)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.11E+00 Statistic Test p-value:2.86E-03; Z-score:1.68E+00

Methylation in Case

7.87E-01 (Median) Methylation in Control 7.11E-01 (Median)

Studied Phenotype

Lung adenocarcinoma[ ICD-11:2C25.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon2

Methylation of SLC37A1 in lung adenocarcinoma [ 8 ]

Location

5'UTR (cg01879556)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.05E+00 Statistic Test p-value:3.32E-03; Z-score:-1.52E+00

Methylation in Case

7.36E-01 (Median) Methylation in Control 7.75E-01 (Median)

Studied Phenotype

Lung adenocarcinoma[ ICD-11:2C25.0]

Experimental Material

Patient tissue samples

  Papillary thyroid cancer

         10 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC37A1 in papillary thyroid cancer [ 9 ]

Location

5'UTR (cg17398613)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.11E+00 Statistic Test p-value:1.16E-08; Z-score:1.36E+00

Methylation in Case

7.71E-01 (Median) Methylation in Control 6.93E-01 (Median)

Studied Phenotype

Papillary thyroid cancer[ ICD-11:2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon2

Methylation of SLC37A1 in papillary thyroid cancer [ 9 ]

Location

5'UTR (cg09546172)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.08E+00 Statistic Test p-value:4.46E-02; Z-score:-5.46E-01

Methylation in Case

1.04E-01 (Median) Methylation in Control 1.12E-01 (Median)

Studied Phenotype

Papillary thyroid cancer[ ICD-11:2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon3

Methylation of SLC37A1 in papillary thyroid cancer [ 9 ]

Location

TSS1500 (cg17218342)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.04E+00 Statistic Test p-value:1.61E-04; Z-score:-7.74E-01

Methylation in Case

7.54E-01 (Median) Methylation in Control 7.81E-01 (Median)

Studied Phenotype

Papillary thyroid cancer[ ICD-11:2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon4

Methylation of SLC37A1 in papillary thyroid cancer [ 9 ]

Location

Body (cg12409874)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.07E+00 Statistic Test p-value:7.03E-09; Z-score:-2.45E+00

Methylation in Case

8.61E-01 (Median) Methylation in Control 9.21E-01 (Median)

Studied Phenotype

Papillary thyroid cancer[ ICD-11:2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon5

Methylation of SLC37A1 in papillary thyroid cancer [ 9 ]

Location

Body (cg13128052)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.04E+00 Statistic Test p-value:2.81E-05; Z-score:-1.19E+00

Methylation in Case

8.58E-01 (Median) Methylation in Control 8.91E-01 (Median)

Studied Phenotype

Papillary thyroid cancer[ ICD-11:2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon6

Methylation of SLC37A1 in papillary thyroid cancer [ 9 ]

Location

Body (cg18478353)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.05E+00 Statistic Test p-value:7.53E-05; Z-score:1.24E+00

Methylation in Case

7.98E-01 (Median) Methylation in Control 7.59E-01 (Median)

Studied Phenotype

Papillary thyroid cancer[ ICD-11:2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon7

Methylation of SLC37A1 in papillary thyroid cancer [ 9 ]

Location

Body (cg08193480)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.02E+00 Statistic Test p-value:2.51E-04; Z-score:-8.41E-01

Methylation in Case

8.92E-01 (Median) Methylation in Control 9.06E-01 (Median)

Studied Phenotype

Papillary thyroid cancer[ ICD-11:2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon8

Methylation of SLC37A1 in papillary thyroid cancer [ 9 ]

Location

Body (cg08529312)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.01E+00 Statistic Test p-value:7.43E-04; Z-score:-5.63E-01

Methylation in Case

8.92E-01 (Median) Methylation in Control 9.03E-01 (Median)

Studied Phenotype

Papillary thyroid cancer[ ICD-11:2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon9

Methylation of SLC37A1 in papillary thyroid cancer [ 9 ]

Location

Body (cg13960334)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.01E+00 Statistic Test p-value:1.32E-03; Z-score:-6.81E-01

Methylation in Case

9.35E-01 (Median) Methylation in Control 9.45E-01 (Median)

Studied Phenotype

Papillary thyroid cancer[ ICD-11:2D10.1]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon10

Methylation of SLC37A1 in papillary thyroid cancer [ 9 ]

Location

Body (cg04096368)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.13E+00 Statistic Test p-value:3.75E-02; Z-score:-7.88E-01

Methylation in Case

3.69E-01 (Median) Methylation in Control 4.19E-01 (Median)

Studied Phenotype

Papillary thyroid cancer[ ICD-11:2D10.1]

Experimental Material

Patient tissue samples

  Systemic lupus erythematosus

           4 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC37A1 in systemic lupus erythematosus [ 10 ]

Location

5'UTR (cg01879556)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.01E+00 Statistic Test p-value:7.41E-03; Z-score:-7.18E-02

Methylation in Case

7.75E-01 (Median) Methylation in Control 7.79E-01 (Median)

Studied Phenotype

Systemic lupus erythematosus[ ICD-11:4A40.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon2

Methylation of SLC37A1 in systemic lupus erythematosus [ 10 ]

Location

TSS1500 (cg08599496)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.01E+00 Statistic Test p-value:2.16E-02; Z-score:-1.39E-01

Methylation in Case

8.58E-01 (Median) Methylation in Control 8.63E-01 (Median)

Studied Phenotype

Systemic lupus erythematosus[ ICD-11:4A40.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon3

Methylation of SLC37A1 in systemic lupus erythematosus [ 10 ]

Location

Body (cg11453546)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.01E+00 Statistic Test p-value:1.97E-02; Z-score:-1.44E-01

Methylation in Case

5.48E-01 (Median) Methylation in Control 5.56E-01 (Median)

Studied Phenotype

Systemic lupus erythematosus[ ICD-11:4A40.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon4

Methylation of SLC37A1 in systemic lupus erythematosus [ 10 ]

Location

Body (cg04192258)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.00E+00 Statistic Test p-value:3.92E-02; Z-score:-1.43E-01

Methylation in Case

9.55E-01 (Median) Methylation in Control 9.57E-01 (Median)

Studied Phenotype

Systemic lupus erythematosus[ ICD-11:4A40.0]

Experimental Material

Patient tissue samples

  Pancretic ductal adenocarcinoma

         14 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC37A1 in pancretic ductal adenocarcinoma [ 11 ]

Location

TSS1500 (cg17816637)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.26E+00 Statistic Test p-value:1.99E-11; Z-score:-2.09E+00

Methylation in Case

4.13E-01 (Median) Methylation in Control 5.19E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon2

Methylation of SLC37A1 in pancretic ductal adenocarcinoma [ 11 ]

Location

TSS1500 (cg14777768)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-3.26E+00 Statistic Test p-value:2.72E-11; Z-score:-2.46E+00

Methylation in Case

1.12E-01 (Median) Methylation in Control 3.65E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon3

Methylation of SLC37A1 in pancretic ductal adenocarcinoma [ 11 ]

Location

TSS1500 (cg14153919)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.24E+00 Statistic Test p-value:1.38E-10; Z-score:1.99E+00

Methylation in Case

6.21E-01 (Median) Methylation in Control 5.03E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon4

Methylation of SLC37A1 in pancretic ductal adenocarcinoma [ 11 ]

Location

TSS1500 (cg13491563)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.10E+00 Statistic Test p-value:2.09E-09; Z-score:-1.32E+00

Methylation in Case

5.83E-01 (Median) Methylation in Control 6.42E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon5

Methylation of SLC37A1 in pancretic ductal adenocarcinoma [ 11 ]

Location

TSS1500 (cg22685369)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.26E+00 Statistic Test p-value:5.27E-09; Z-score:8.24E-01

Methylation in Case

5.24E-02 (Median) Methylation in Control 4.17E-02 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon6

Methylation of SLC37A1 in pancretic ductal adenocarcinoma [ 11 ]

Location

TSS1500 (cg04395689)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:2.14E+00 Statistic Test p-value:1.70E-06; Z-score:1.65E+00

Methylation in Case

3.97E-01 (Median) Methylation in Control 1.86E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon7

Methylation of SLC37A1 in pancretic ductal adenocarcinoma [ 11 ]

Location

TSS1500 (cg04433322)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.17E+00 Statistic Test p-value:1.05E-03; Z-score:-1.06E+00

Methylation in Case

5.40E-01 (Median) Methylation in Control 6.34E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon8

Methylation of SLC37A1 in pancretic ductal adenocarcinoma [ 11 ]

Location

Body (cg18865990)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.40E+00 Statistic Test p-value:1.77E-11; Z-score:-1.96E+00

Methylation in Case

3.79E-01 (Median) Methylation in Control 5.31E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon9

Methylation of SLC37A1 in pancretic ductal adenocarcinoma [ 11 ]

Location

Body (cg08894629)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.39E+00 Statistic Test p-value:2.15E-04; Z-score:-8.12E-01

Methylation in Case

9.52E-02 (Median) Methylation in Control 1.32E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon10

Methylation of SLC37A1 in pancretic ductal adenocarcinoma [ 11 ]

Location

Body (cg15507500)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.02E+00 Statistic Test p-value:8.02E-03; Z-score:1.13E+00

Methylation in Case

9.28E-01 (Median) Methylation in Control 9.12E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon11

Methylation of SLC37A1 in pancretic ductal adenocarcinoma [ 11 ]

Location

Body (cg09050775)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.19E+00 Statistic Test p-value:8.70E-03; Z-score:8.40E-01

Methylation in Case

5.11E-01 (Median) Methylation in Control 4.28E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon12

Methylation of SLC37A1 in pancretic ductal adenocarcinoma [ 11 ]

Location

Body (cg21821674)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.14E+00 Statistic Test p-value:1.12E-02; Z-score:6.66E-01

Methylation in Case

4.92E-01 (Median) Methylation in Control 4.30E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon13

Methylation of SLC37A1 in pancretic ductal adenocarcinoma [ 11 ]

Location

Body (cg06660015)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.19E+00 Statistic Test p-value:1.14E-02; Z-score:-7.14E-01

Methylation in Case

2.47E-01 (Median) Methylation in Control 2.94E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon14

Methylation of SLC37A1 in pancretic ductal adenocarcinoma [ 11 ]

Location

Body (cg15999077)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.06E+00 Statistic Test p-value:2.24E-02; Z-score:-4.81E-01

Methylation in Case

5.07E-01 (Median) Methylation in Control 5.37E-01 (Median)

Studied Phenotype

Pancretic ductal adenocarcinoma[ ICD-11:2C10.0]

Experimental Material

Patient tissue samples

  Prostate cancer

           3 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC37A1 in prostate cancer [ 12 ]

Location

TSS1500 (cg15930596)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.49E+00 Statistic Test p-value:4.01E-02; Z-score:6.00E+00

Methylation in Case

1.40E-01 (Median) Methylation in Control 9.36E-02 (Median)

Studied Phenotype

Prostate cancer[ ICD-11:2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon2

Methylation of SLC37A1 in prostate cancer [ 12 ]

Location

TSS1500 (cg22685369)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.35E+00 Statistic Test p-value:4.74E-02; Z-score:-3.96E+00

Methylation in Case

3.00E-02 (Median) Methylation in Control 4.04E-02 (Median)

Studied Phenotype

Prostate cancer[ ICD-11:2C82]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon3

Methylation of SLC37A1 in prostate cancer [ 12 ]

Location

Body (cg06903325)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.03E+00 Statistic Test p-value:3.57E-02; Z-score:1.29E+00

Methylation in Case

9.60E-01 (Median) Methylation in Control 9.36E-01 (Median)

Studied Phenotype

Prostate cancer[ ICD-11:2C82]

Experimental Material

Patient tissue samples

  Colon cancer

           4 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC37A1 in colon adenocarcinoma [ 13 ]

Location

Body (cg13551505)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.44E+00 Statistic Test p-value:1.12E-07; Z-score:-3.44E+00

Methylation in Case

3.96E-01 (Median) Methylation in Control 5.70E-01 (Median)

Studied Phenotype

Colon cancer[ ICD-11:2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon2

Methylation of SLC37A1 in colon adenocarcinoma [ 13 ]

Location

Body (cg01082559)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:-1.09E+00 Statistic Test p-value:1.26E-04; Z-score:-2.45E+00

Methylation in Case

7.65E-01 (Median) Methylation in Control 8.37E-01 (Median)

Studied Phenotype

Colon cancer[ ICD-11:2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon3

Methylation of SLC37A1 in colon adenocarcinoma [ 13 ]

Location

Body (cg08581937)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:3.05E+00 Statistic Test p-value:8.16E-04; Z-score:3.57E+00

Methylation in Case

2.15E-01 (Median) Methylation in Control 7.06E-02 (Median)

Studied Phenotype

Colon cancer[ ICD-11:2B90]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon4

Methylation of SLC37A1 in colon adenocarcinoma [ 13 ]

Location

Body (cg24944109)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.32E+00 Statistic Test p-value:3.29E-03; Z-score:1.32E+00

Methylation in Case

3.09E-01 (Median) Methylation in Control 2.34E-01 (Median)

Studied Phenotype

Colon cancer[ ICD-11:2B90]

Experimental Material

Patient tissue samples

  Panic disorder

           2 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Methylation of SLC37A1 in panic disorder [ 14 ]

Location

Body (cg12409874)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.06E+00 Statistic Test p-value:1.68E-03; Z-score:6.03E-01

Methylation in Case

2.79E+00 (Median) Methylation in Control 2.62E+00 (Median)

Studied Phenotype

Panic disorder[ ICD-11:6B01]

Experimental Material

Patient tissue samples

  Epigenetic Phenomenon2

Methylation of SLC37A1 in panic disorder [ 14 ]

Location

Body (cg08529312)

Epigenetic Type

Methylation Experiment Method Infinium HumanMethylation450 BeadChip

Methylation Fold Change

Fold Change:1.08E+00 Statistic Test p-value:2.07E-02; Z-score:5.71E-01

Methylation in Case

2.80E+00 (Median) Methylation in Control 2.60E+00 (Median)

Studied Phenotype

Panic disorder[ ICD-11:6B01]

Experimental Material

Patient tissue samples

  Cerebellar liponeurocytoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Moderate hypermethylation of SLC37A1 in cerebellar liponeurocytoma than that in healthy individual

Studied Phenotype

Cerebellar liponeurocytoma [ICD-11:2A00.0Y]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value:0.007416241; Fold-change:0.236321798; Z-score:1.528412788
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Chordoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Moderate hypermethylation of SLC37A1 in chordoma than that in healthy individual

Studied Phenotype

Chordoma [ICD-11:5A61.0]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value:0.00189494; Fold-change:0.259010689; Z-score:1.485990013
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Craniopharyngioma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Moderate hypermethylation of SLC37A1 in craniopharyngioma than that in healthy individual

Studied Phenotype

Craniopharyngioma [ICD-11:2F9A]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value:2.87E-09; Fold-change:0.211924252; Z-score:1.398096231
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Melanocytoma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Moderate hypermethylation of SLC37A1 in melanocytoma than that in healthy individual

Studied Phenotype

Melanocytoma [ICD-11:2F36.2]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value:2.24E-11; Fold-change:0.277512459; Z-score:2.351163478
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Oligodendroglioma

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Moderate hypermethylation of SLC37A1 in oligodendroglioma than that in healthy individual

Studied Phenotype

Oligodendroglioma [ICD-11:2A00.0Y]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value:8.75E-20; Fold-change:0.207985187; Z-score:1.519737076
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Chronic myelogenous leukemia

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Moderate hypomethylation of SLC37A1 in chronic myelogenous leukaemia than that in healthy individual

Studied Phenotype

Chronic myelogenous leukemia [ICD-11:2A20.0]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value:0.014111374; Fold-change:-0.299646286; Z-score:-1.346764594
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

  Multilayered rosettes embryonal tumour

           1 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

Significant hypomethylation of SLC37A1 in multilayered rosettes embryonal tumour than that in healthy individual

Studied Phenotype

Multilayered rosettes embryonal tumour [ICD-11:2A00.1]

The Methylation Level of Disease Section Compare with the Healthy Individual

p-value:6.71E-20; Fold-change:-0.365086283; Z-score:-2.690029482
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
Please Click the above Thumbnail to View/Download
the Methylation Barchart for All Samples

microRNA

  Unclear Phenotype

           3 Epigenetic Phenomena Related to This Phenotype Click to Show/Hide the Full List

  Epigenetic Phenomenon1

miR-19a directly targets SLC37A1 [ 15 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-19a miRNA Mature ID miR-19a-3p

miRNA Sequence

UGUGCAAAUCUAUGCAAAACUGA

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon2

miR-19b directly targets SLC37A1 [ 15 ]

Epigenetic Type

microRNA Experiment Method HITS-CLIP

miRNA Stemloop ID

miR-19b miRNA Mature ID miR-19b-3p

miRNA Sequence

UGUGCAAAUCCAUGCAAAACUGA

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human

  Epigenetic Phenomenon3

miR-335 directly targets SLC37A1 [ 16 ]

Epigenetic Type

microRNA Experiment Method Microarray

miRNA Stemloop ID

miR-335 miRNA Mature ID miR-335-5p

miRNA Sequence

UCAAGAGCAAUAACGAAAAAUGU

miRNA Target Type

Direct

Experimental Material

Multiple cell lines of human
References
1 Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes. Cancer Cell. 2016 Mar 14;29(3):379-393.
2 DNA Methylation Dynamics in Urological Tumors.
3 Genome-wide Scan for Methylation Profiles in Breast Cancer
4 A CpG-methylation-based assay to predict survival in clear cell renal cell carcinoma. Nat Commun. 2015 Oct 30;6:8699.
5 Differences in DNA methylation signatures reveal multiple pathways of progression from adenoma to colorectal cancer. Gastroenterology. 2014 Aug;147(2):418-29.e8.
6 Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips. Epigenetics. 2013 Jan;8(1):34-43.
7 HIV-1 Infection Accelerates Age According to the Epigenetic Clock. J Infect Dis. 2015 Nov 15;212(10):1563-73.
8 DNA methylation analysis of lung adenocarcinoma and adjacent non-tumor tissues
9 Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors. J Clin Endocrinol Metab. 2017 Nov 1;102(11):4089-4099.
10 Genome-wide DNA methylation analysis of systemic lupus erythematosus reveals persistent hypomethylation of interferon genes and compositional changes to CD4+ T-cell populations. PLoS Genet. 2013;9(8):e1003678.
11 Genome-wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT-ROBO, ITGA2 and MET signaling. Int J Cancer. 2014 Sep 1;135(5):1110-8.
12 Reducing the risk of false discovery enabling identification of biologically significant genome-wide methylation status using the HumanMethylation450 array. BMC Genomics. 2014 Jan 22;15:51.
13 Genome-scale analysis of DNA methylation in colorectal cancer using Infinium HumanMethylation450 BeadChips. Epigenetics. 2013 Sep;8(9):921-34.
14 DNA Methylation signatures in panic disorder. Transl Psychiatry. 2017 Dec 18;7(12):1287.
15 EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency. EMBO J. 2012 May 2;31(9):2207-21.
16 Endogenous human microRNAs that suppress breast cancer metastasis. Nature. 2008 Jan 10;451(7175):147-52.

If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.